ZMUni Compliance Centre

Recently, ZMUni Compliance Centre successfully supported XtalPi Holdings Limited (2228.HK) in securing a U.S. Self-affirmed GRAS determination for Tensotide™, an innovative oral peptide ingredient designed for blood glucose management. Developed through XtalPi's proprietary AI-powered peptide platform PepiX™, Tensotide™ is now cleared for lawful use in foods and dietary supplements in the United States, enabling a significant step forward in its global commercialization pathway.   This milestone represents another key achievement for XtalPi in the consumer health space and highlights ZMUni Compliance Centre's strong capabilities in overseas food regulatory compliance and international market access for novel and innovative ingredients, consistently enabling

The global cosmetics regulatory environment continues to evolve. To help businesses stay updated with regulatory changes, ZMUni Compliance Center regularly releases a monthly recap of global cosmetics regulations. This article covers the regulatory developments related to cosmetics in China and globally in June 2026, with an emphasis on updates in cosmetic ingredients and cosmetic management, among other areas.   China Cosmetic Regulatory Updates New Cosmetics Ingredients (NCI)   In June 2026, 23 new cosmetic ingredients were notified with the China National Medical Products Administration (NMPA). They include:   The technical requirements for the 23 NCIs mentioned above have not been

    During the last week of June 2026, a total of six new cosmetic ingredients completed notification with China's National Medical Products Administration (NMPA). The technical requirements for all related NCIs have not been publicly disclosed.     Ginsenoside Compound K (Notification No.20260111)   According to the notifier Giant Biogene, this Ginsenoside Compound K adopts a differentiated production pathway, integrating an enzyme-directed biotransformation process with high-purity preparative separation technology for rare ginsenosides.   The notified ingredient is positioned for skin barrier repair and sebum regulation, addressing key concerns in oily and acne-prone skin.     Photoinitiators (Notification No.20260113 and

    On June 30, 2026, China's National Medical Products Administration (NMPA) released a comprehensive consultation draft titled Administrative Measures for Cosmetic Standards(Draft For Comments). The draft aims to strengthen and standardize the regulatory framework governing cosmetics—including toothpaste—to ensure product safety and support high-quality industry development. Stakeholders may submit comments until July 30, 2026.   The draft clarifies a structured three-tier framework for cosmetic standards, further defining the hierarchy, scope of application, and regulatory force of different technical requirements:   Mandatory National Standards: Legally binding requirements designed to protect public health and safety, covering core terminology, labeling, and general safety

Recently, ZMUni Compliance Centre has successfully supported multiple cosmetic brands in navigating and completing regulatory compliance across key global markets—including the United States (and California), Canada, Taiwan (China), Japan, ASEAN (Malaysia, Indonesia, Thailand, Vietnam), and the United Kingdom.   These projects cover a wide range of cosmetic categories, from skincare products such as moisturisers, cleansers, anti-aging, and brightening formulations, to colour cosmetics, haircare, and full-range personal care products.     United States   Our recent compliance achievements in the US market span a diverse range of product categories, including moisturisers, skincare gels and oils, cleansing gels/milks, hydrating masks, serums, clay

  On June 26, China's National Medical Products Administration (NMPA) issued the Provisions for Management of New Cosmetic Ingredient Registration and Notification Dossiers (hereinafter the "New Provisions"), effective July 15, replacing the 2021 version. The new rules consist of 15 articles and aim to clarify regulatory boundaries, streamline administrative requirements, and encourage innovation by reducing compliance burdens for new cosmetic ingredient development.   The revised framework separates administrative and technical requirements, removing detailed technical content such as development reports, manufacturing processes, and safety assessment materials from the regulation and instead linking them to technical guidance documents. It also introduces updated

    On June 22, 2026, China's General Administration of Customs (GACC) released its list of non-compliant imported food products for May 2026. A total of 706 batches from 43 countries and regions were denied entry, representing a month-on-month increase of approximately 52% (up 243 batches from 463 in March 2026) and a year-on-year increase of about 65% (up 278 batches from 428 in the same period last year).   The rejected shipments spanned a wide array of categories, including dairy, vegetable oils, alcoholic beverages, frozen livestock and seafood, snacks, and beverages. Geographically, Ecuador saw the most significant spike, accounting

From June 15 to June 23, 2026, 7 new cosmetic ingredients (NCIs) have completed notifications with China's National Medical Products Administration (NMPA). The technical requirements have not been disclosed yet.     Polymers   Notification No. 20260104  Hydrogenated Soy Polyglycerides is the product obtained through catalytic metathesis of Glycine Soja (Soybean) Oil, followed by hydrogenation. According to PCPC, its functions include Skin-Conditioning Agent (Occlusive) and Viscosity Increasing Agent (Nonaqueous). This notification marks the first NCI submission from a Singapore-based company under China's NCI framework.   Notification No. 20260105 and Notification No. 20260106 In this issue, Intercos S.p.A. notified two NCIs, both